Table of Contents Author Guidelines Submit a Manuscript
Advances in Bioinformatics
Volume 2014 (2014), Article ID 324753, 18 pages
http://dx.doi.org/10.1155/2014/324753
Research Article

Alternate Phosphorylation/O-GlcNAc Modification on Human Insulin IRSs: A Road towards Impaired Insulin Signaling in Alzheimer and Diabetes

1Department of Chemistry, GC University Lahore, Lahore, Pakistan
2School of Biological Sciences, Goddard Building, The University of Queensland, Brisbane, QLD 4072, Australia

Received 24 August 2014; Accepted 10 November 2014; Published 17 December 2014

Academic Editor: Jian-Liang Li

Copyright © 2014 Zainab Jahangir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Selkoe, “Alzheimer's disease: genotypes, phenotype, and treatments,” Science, vol. 275, no. 5300, pp. 630–631, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. Alzheimer's Association, “2012 Alzheimer's disease facts and figures,” Alzheimer's & Dementia, vol. 8, no. 2, pp. 131–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. W. H. Gispen and G.-J. Biessels, “Cognition and synaptic plasticity in diabetes mellitus,” Trends in Neurosciences, vol. 23, no. 11, pp. 542–549, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hoyer, “Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis,” Journal of Neural Transmission, vol. 105, no. 4-5, pp. 415–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. de la Monte and J. R. Wands, “Alzheimer's disease is type 3 diabetes-evidence reviewed,” Journal of Diabetes Science and Technology, vol. 2, no. 6, pp. 1101–1113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Ahmad, “Overlapped metabolic and therapeutic links between Alzheimer and diabetes,” Molecular Neurobiology, vol. 47, no. 1, pp. 399–424, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-K. Sun and D. L. Alkon, “Links between Alzheimer's disease and diabetes,” Drugs of Today, vol. 42, no. 7, pp. 481–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Deng, B. Li, Y. Liu, K. Iqbal, I. Grundke-Iqbal, and C.-X. Gong, “Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer's disease,” The American Journal of Pathology, vol. 175, no. 5, pp. 2089–2098, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. D. Ke, F. Delerue, A. Gladbach, J. Götz, and L. M. Ittner, “Experimental diabetes mellitus exacerbates Tau pathology in a transgenic mouse model of Alzheimer's disease,” PLoS ONE, vol. 4, no. 11, Article ID e7917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Sesti, M. Federici, M. L. Hribal, D. Lauro, P. Sbraccia, and R. Lauro, “Defects of the insulin receptor substrate (IRS) system in human metabolic disorders,” FASEB Journal, vol. 15, no. 12, pp. 2099–2111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Withers, D. J. Burks, H. H. Towery, S. L. Altamuro, C. L. Flint, and M. F. White, “Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling,” Nature Genetics, vol. 23, no. 1, pp. 32–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Withers, J. S. Gutierrez, H. Towery et al., “Disruption of IRS-2 causes type 2 diabetes in mice,” Nature, vol. 391, no. 6670, pp. 900–904, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Selman, S. Lingard, A. I. Choudhury et al., “Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice,” FASEB Journal, vol. 22, no. 3, pp. 807–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Taguchi, L. M. Wartschow, and M. F. White, “Brain IRS2 signaling coordinates life span and nutrient homeostasis,” Science, vol. 317, no. 5836, pp. 369–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Schubert, D. P. Brazil, D. J. Burks et al., “Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation,” The Journal of Neuroscience, vol. 23, no. 18, pp. 7084–7092, 2003. View at Google Scholar · View at Scopus
  16. A. M. Moloney, R. J. Griffin, S. Timmons, R. O'Connor, R. Ravid, and C. O'Neill, “Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling,” Neurobiology of Aging, vol. 31, no. 2, pp. 224–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. Dearth, X. Cui, H.-J. Kim, D. L. Hadsell, and A. V. Lee, “Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2,” Cell Cycle, vol. 6, no. 6, pp. 705–713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mann and O. N. Jensen, “Proteomic analysis of post-translational modifications,” Nature Biotechnology, vol. 21, no. 3, pp. 255–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Summers, “Ceramides in insulin resistance and lipotoxicity,” Progress in Lipid Research, vol. 45, no. 1, pp. 42–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Sesti, “Pathophysiology of insulin resistance,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 20, no. 4, pp. 665–679, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. W. Greene, H. Sakaue, L. Wang, D. R. Alessi, and R. A. Roth, “Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation,” The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8199–8211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Griffin, A. Moloney, M. Kelliher et al., “Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology,” Journal of Neurochemistry, vol. 93, no. 1, pp. 105–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Rui, V. Aguirre, J. K. Kim et al., “Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 181–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zick, “Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance,” Science's STKE, vol. 2005, no. 268, p. pe4, 2005. View at Google Scholar
  25. H. Yu and T. Rohan, “Role of the insulin-like growth factor family in cancer development and progression,” Journal of the National Cancer Institute, vol. 92, no. 18, pp. 1472–1489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Firth and R. C. Baxter, “Cellular actions of the insulin-like growth factor binding proteins,” Endocrine Reviews, vol. 23, no. 6, pp. 824–854, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Ahmad, K. Shabbiri, B. Ijaz et al., “Serine 204 phosphorylation and O - GlcNAC interplay of IGFBP-6 as therapeutic indicator to regulate IGF-II functions in viral mediated hepatocellular carcinoma,” Virology Journal, vol. 8, article 208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. H. Wu, R. Apweiler, A. Bairoch et al., “The Universal Protein Resource (UniProt): an expanding universe of protein information,” Nucleic Acids Research, vol. 34, pp. D187–D191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. N. E. Zachara and G. W. Hart, “The emerging significance of O-GlcNAc in cellular regulation,” Chemical Reviews, vol. 102, no. 2, pp. 431–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. F. White, “Regulating insulin signaling and β-cell function through IRS proteins,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 7, pp. 725–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. F. Petersen and G. I. Shulman, “Etiology of insulin resistance,” American Journal of Medicine, vol. 119, no. 5, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. D'Alessandris, F. Andreozzi, M. Federici et al., “Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic β-cells,” The FASEB Journal, vol. 18, no. 9, pp. 959–961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. A. L. Kleini, M. N. Berkaw, M. G. Buse, and L. E. Ball, “O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs,” Molecular and Cellular Proteomics, vol. 8, no. 12, pp. 2733–2745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. L. E. Ball, M. N. Berkaw, and M. G. Buse, “Identification of the major site of O-linked β-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1,” Molecular and Cellular Proteomics, vol. 5, no. 2, pp. 313–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Eswar, B. Webb, M. A. Marti-Renom et al., “Unit 5.6. Chapter 5. Comparative protein structure modeling using modeller,” in Current Protocols in Bioinformatics, 2006. View at Google Scholar
  36. Y. Zhang, “I-TASSER server for protein 3D structure prediction,” BMC Bioinformatics, vol. 9, article 40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Arnold, L. Bordoli, J. Kopp, and T. Schwede, “The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling,” Bioinformatics, vol. 22, no. 2, pp. 195–201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. I. W. Davis, L. W. Murray, J. S. Richardson, and D. C. Richardson, “MolProbity: structure validation and all-atom contact analysis for nucleic acids and their complexes,” Nucleic Acids Research, vol. 32, pp. W615–W619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. E. F. Pettersen, T. D. Goddard, C. C. Huang et al., “UCSF Chimera—a visualization system for exploratory research and analysis,” Journal of Computational Chemistry, vol. 25, no. 13, pp. 1605–1612, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Baldi and S. Brunak, Bioinformatics: The Machine Learning Approach, MIT Press, Cambridge, Mass, USA, 2nd edition, 2001.
  41. W. Ahmad, K. Shabbiri, B. Ijaz et al., “Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation,” Virology Journal, vol. 8, article 229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Ahmad, K. Shabbiri, N. Nazar, S. Nazar, S. Qaiser, and M. A. S. Mughal, “Human linker histones: interplay between phosphorylation and O-β-GlcNAc to mediate chromatin structural modifications,” Cell Division, vol. 6, article 15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Blom, S. Gammeltoft, and S. Brunak, “Sequence and structure-based prediction of eukaryotic protein phosphorylation sites,” Journal of Molecular Biology, vol. 294, no. 5, pp. 1351–1362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Songyang, S. Blechner, N. Hoagland, M. F. Hoekstra, H. Piwnica-Worms, and L. C. Cantley, “Use of an oriented peptide library to determine the optimal substrates of protein kinases,” Current Biology, vol. 4, no. 11, pp. 973–982, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Blom, T. Sicheritz-Pontén, R. Gupta, S. Gammeltoft, and S. Brunak, “Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence,” Proteomics, vol. 4, no. 6, pp. 1633–1649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-D. Huang, T.-Y. Lee, S.-W. Tzeng, and J.-T. Horng, “KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites,” Nucleic Acids Research, vol. 33, no. 2, pp. W226–W229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Diella, S. Cameron, C. Gemünd et al., “Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins,” BMC Bioinformatics, vol. 5, article 79, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Gupta and S. Brunak, “Prediction of glycosylation across the human proteome and the correlation to protein function,” Pacific Symposium on Biocomputing, pp. 310–322, 2002. View at Google Scholar
  49. B. Petersen, T. N. Petersen, P. Andersen, M. Nielsen, and C. Lundegaard, “A generic method for assignment of reliability scores applied to solvent accessibility predictions,” BMC Structural Biology, vol. 9, article 51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. J. C. Obenauer, L. C. Cantley, and M. B. Yaffe, “Scansite 2.0: proteome-wide prediction of cell signalling interactions using short sequence motifs,” Nucleic Acids Research, vol. 31, no. 13, pp. 3635–3641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Sharfi and H. Eldar-Finkelman, “Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling,” American Journal of Physiology: Endocrinology and Metabolism, vol. 294, no. 2, pp. E307–E315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Ahmad, D. C. Hoessli, E. Walker-Nasir, S. M. Rafik, and A. R. Shakoori, “Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation,” Nucleic Acids Research, vol. 34, no. 1, pp. 175–184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Kaleem, D. C. Hoessli, I. Ahmad et al., “Immediate-early gene regulation by interplay between different post-translational modifications on human histone H3,” Journal of Cellular Biochemistry, vol. 103, no. 3, pp. 835–851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Kaleem, D. C. Hoessli, I.-U. Haq et al., “CREB in long-term potentiation in hippocampus: role of post-translational modifications-studies in silico,” Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 138–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Gao, D. Hwang, F. Bataille et al., “Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex,” Journal of Biological Chemistry, vol. 277, no. 50, pp. 48115–48121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Haruta, T. Uno, J. Kawahara et al., “A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1,” Molecular Endocrinology, vol. 14, no. 6, pp. 783–794, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. W.-L. An, R. F. Cowburn, L. Li et al., “Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease,” The American Journal of Pathology, vol. 163, no. 2, pp. 591–607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. S. S. Neukamm, R. Toth, N. Morrice et al., “Identification of the Amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573,” PLoS ONE, vol. 7, no. 8, Article ID e43296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Zhande, W. Zhang, Y. Zheng et al., “Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2,” The Journal of Biological Chemistry, vol. 281, no. 51, pp. 39071–39080, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Liu, J. Shi, H. Tanimukai et al., “Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease,” Brain, vol. 132, no. 7, pp. 1820–1832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Yu, L. Zhang, X. Li et al., “Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation,” PLoS ONE, vol. 7, no. 4, Article ID e35277, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. S. A. Yuzwa, X. Shan, M. S. MacAuley et al., “Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation,” Nature Chemical Biology, vol. 8, no. 4, pp. 393–399, 2012. View at Publisher · View at Google Scholar · View at Scopus